Recent Press Releases   7/28/08   Biolex Therapeutics Adds $10.5 Million in Growth Capital 7/22/08   Oxford Finance Corporation and Silicon Valley Bank Close $12 Million Secured Loan Agreement with Medivance, Inc. 6/3/08   Oxford Finance Corporation and ATEL Ventures, Inc. Provide $7.5 Million Venture Loan to AxoGen, Inc. 5/23/08   Somaxon Pharmaceuticals Secures up to $65 Million in Financing 5/7/08   MAP Pharmaceuticals Secures $20 Million in Debt Financing 4/30/08   Oxford Finance Corporation and Comerica Bank Provide $15 Million Loan Facility to VisualSonics Inc. 3/31/08   Aerovance Secures $20 Million in Debt Financing 2/21/08   Renal Solutions, Inc., a Portfolio Company of ATEL Ventures, Inc. and Oxford Finance Corporation, Acquired by Fresenius Medical Care AG & Co. KGaA 11/15/07   BioVex Closes Second Round of Series E Financing 11/7/07   Oxford Finance Corporation and GE Healthcare Financial Services Reaffirm Commitment to Biotech Sector in Europe 9/25/07   Oxford Finance Corporation Closes $7 Million Debt Facility with Othera Pharmaceuticals 9/17/07   Oxford Finance Corporation Sponsors 2007 Mid-Atlantic Bio 9/17/07   Entremed Raises $20 Million to Support Clinical Development Program 9/12/07   Oxford Finance Corporation Hires Timothy A. Lex to Serve as Chief Operation Officer 8/21/07   CryoCor Completes New Credit Facility 7/17/07 Rubicor Medical, Inc. Receives $10 Million in Financing to Further Growth Opportunity